Biomaterial Database

Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines. 1977

J A Ferguson, and W C Reeves, and J L Hardy

Serologic studies in 24 ponies indicated that prevaccination antibodies to Venezuelan equine encephalomyelitis (VEE) virus (strain TC-83) had no influence on hemagglutination-inhibition (HI) antibody stimulation by western equine encephalomyelitis (WEE) or eastern equine encephalomyelits (EEE)-WEE vaccines. However, studies of the effects of VEE neutralizing antibodies on neutralizing antibody stimulation by the heterologous alphavirus vaccines were inconclusive. The VEE, WEE, and EEE antibody responses were studied in 18 VEE-vaccinated (strain TC-83) animals (13 ponies and 5 horses) at 9 to 14 months after challenge of immunity with virulent VEE virus. The VEE HI, and neutralizing antibodies in combination were associated with greater suppression of VEE antibody stimulation than were VEE neutralizing antibodies alone. The VEE geometric mean antibody titers (GMT) increased 26- and 64-fold for HI antibodies and for neutralizing antibodies, respectively, in 5 animals that had prechallenge exposure titers of VEE neutralizing antibodies only. In contrast, the GMT increased only threefold and eightfold for VEE HI antibodies and for neutralizing antibodies, respectively, in 8 animals that had prechallenge exposure titers of both VEE HI and neutralizing antibodies. Five animals which were seronegative for prechallenge VEE antibodies and had survived challenge exposure gave primary VEE-immune response. Protection in these animals may have resulted from high-titer cross-reacting antibodies to WEE or EEE viruses, or both. Changes in the GMT for WEE HI, neutralizing, and complement-fixation antibodies after challenge exposure were statistically insignificant. However, a statistically significant increase in the EEE HI-GMT occurred in ponies that had low (or no) prechallenge exposure titers of VEE antibodies.

UI	MeSH Term	Description	Entries
D009500	Neutralization Tests	The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).	Neutralization Test,Test, Neutralization,Tests, Neutralization
D004663	Encephalitis Virus, Eastern Equine	A species of ALPHAVIRUS causing encephalomyelitis in Equidae and humans. The virus ranges along the Atlantic seaboard of the United States and Canada and as far south as the Caribbean, Mexico, and parts of Central and South America. Infections in horses show a mortality of up to 90 percent and in humans as high as 80 percent in epidemics.	EEE Virus,Eastern Equine Encephalomyelitis Virus,Eastern equine encephalitis virus,Encephalomyelitis Virus, Eastern Equine,EEE Viruses
D004666	Encephalitis Virus, Venezuelan Equine	A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines. It is seen most commonly in parts of Central and South America.	Encephalomyelitis Virus, Venezuelan Equine,Encephalitis Viruses, Venezuelan Equine,Venezuelan Equine Encephalitis Viruses,Venezuelan equine encephalitis virus,Virus, Venezuelan Equine Encephalitis,Viruses, Venezuelan Equine Encephalitis
D004667	Encephalitis Virus, Western Equine	A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines in the United States, southern Canada, and parts of South America.	Encephalomyelitis Virus, Western Equine,WEE Virus,Western equine encephalitis virus,Encephalitis Viruses, Western Equine,Virus, Western Equine Encephalitis,Viruses, Western Equine Encephalitis,Western Equine Encephalitis Viruses,WEE Viruses
D004668	Encephalitis Viruses	A collection of single-stranded RNA viruses scattered across the Bunyaviridae, Flaviviridae, and Togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts.	Encephalitis Virus,Virus, Encephalitis,Viruses, Encephalitis
D006385	Hemagglutination Inhibition Tests	Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.	Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006736	Horses	Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.	Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D000914	Antibodies, Viral	Immunoglobulins produced in response to VIRAL ANTIGENS.	Viral Antibodies
D000917	Antibody Formation	The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.	Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody